Primary cutaneous follicular lymphoma: An assessment of clinical, histopathologic, immunophenotypic, and molecular features

Journal of Clinical Oncology

Volumn 20, Issue 3, 2002, Pages 647-655

  Mirza, I ^a   Macpherson, N ^a   Paproski, S ^a   Gascoyne, R D ^a   Yang, B ^a   Finn, W G ^a   Hsi, E D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CD20 ANTIGEN; CD3 ANTIGEN; CHLORAMBUCIL; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN HEAVY CHAIN; METHOTREXATE; PREDNISONE; PROTEIN BCL 2; PROTEIN BCL 6; VINCRISTINE;

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX RATIO; SKIN LYMPHOMA; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD20; ANTIGENS, CD3; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEPRILYSIN; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-BCL-6; SEQUENCE ANALYSIS, DNA; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0036467823     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.3.647     Document Type: Article

References (51)

1. Some statistical data, diagnosis, and staging of cutaneous B-cell lymphomas
2. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue
3. Skin involvement of malignant B-cell lymphomas
4. Cutaneous B-cell lymphoproliferative disease: A centenary celebration classification
5. EORTC classification for primary cutaneous lymphomas: A proposal from the cutaneous lymphoma study group of the European organization for research and treatment of cancer
6. Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: A clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy
7. Primary cutaneous large cell lymphomas of follicular center cell origin
8. Primary cutaneous follicular center-cell lymphoma: A lymphoproliferative disease with favorable prognosis
9. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group
10. World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues
11. EORTC classification for primary cutaneous lymphomas: The best guide to good clinical management. European organization for research and treatment of cancer
12. Primary cutaneous B-cell lymphoma: How useful is the new European organization for research and treatment of cancer (EORTC) classification?
13. Classification of cutaneous lymphoma: A critical appraisal of recent proposals
14. A critique of classifications of lymphoma in historical perspective (and a proposal for how a classification that actually works can be formulated)
15. Cutaneous lymphomas: A proposal for a unified approach to classification using the REAL/WHO classification
16. The revised European-American classification of lymphoid neoplasms (REAL): A new perspective for the classification of cutaneous lymphomas
17. The revised European-American classification of lymphoid neoplasms (REAL): A preferred approach for the classification of cutaneous lymphomas
18. EORTC classification for primary cutaneous lymphomas: A comparison with the R.E.A.L. classification and the proposed WHO classification
19. Cutaneous lymphoma: Understanding the new classification schemes
20. The revised European-American classification of lymphoid neoplasms (REAL): A new perspective for the classification of cutaneous lymphomas
21. Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization
22. Criteria for the cytologic subclassification of follicular lymphomas: A proposed alternative method
23. Identification of monoclonal B-cell populations by rapid cycle polymerase chain reaction: A practical screening method for the detection of immunoglobulin gene rearrangements
24. Monoclonality in B-cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction
25. Primary cutaneous B-cell lymphoma: Review and current concepts
26. Reticulohistiocytoma of the dorsum
27. Radiotherapy of cutaneous B-cell lymphomas: Our experience in 31 cases
28. Primary cutaneous B-cell lymphoma: A unique type of low-grade lymphoma: Clinicopathologic and immunologic study of 83 cases
29. Cutaneous follicle center lymphoma: A study of 24 cases
30. Primary cutaneous follicle center cell lymphoma with follicular growth pattern
31. Bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas
32. Immunoreactivity for bcl- 2 protein in cutaneous lymphomas and lymphoid hyperplasias
33. Clinicopathologic, immunophenotypic, and molecular characterization of primary cutaneous follicular B-cell lymphoma
34. Cutaneous B-cell lymphomas of follicular and marginal zone types: Use of Bcl-6, CD 10, Bcl- 2, and CD21 in differential diagnosis and classification
35. Cutaneous follicular B-cell lymphoma: Description of a series of 18 cases
36. NIH conference: Epstein-Barr virus infections-biology, pathogenesis, and management
37. Borrelia burgdorferi-associated cutaneous B-cell lymphoma: Clinical and immunohistologic characterization of four cases
38. Borrelia burgdorferi-associated primary cutaneous B-cell lymphoma: Complete clearing of skin lesions after antibiotic pulse therapy or interlesional injection of interferon alfa- 2a
39. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma
40. Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infections in patients from the highlands of Scotland
41. Primary cutaneous immunocytoma: A B-cell lymphoma that can easily be mistaken for cutaneous lymphoid hyperplasia
42. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosis et atrophicus of patients from North America
43. Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma
44. Polymerase chain reaction in the diagnosis of chromosomal breakpoints
45. Follicular lymphoma
46. Expression of the bcl- 2 gene product in follicular lymphoma
47. Frequency of bcl-2 expression in non-Hodgkins' lymphoma: A study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia
48. Bcl-2 expression in non-Hodgkin's lymphomas is not associated with bcl- 2 gene rearrangements
49. Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas
50. Somatic point mutations in the translocated bcl-2 genes of non-Hodgkin's lymphomas and lymphocytic leukemias: Implications for mechanisms of tumor progression
51. Comparison of t(14;18) positive and t(14;18) negative follicular lymphoma (FL): Clinical characteristics, outcome, and cytogenetics